Nurse Practitioner, Family · Minneapolis, MN
NPI
1790379261
Since 2021
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
715 S 8th St
Minneapolis, MN, 55404
Phone (612) 873-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$25K
828 services
Medicare patients, 2024
67
Average age 61
Drug cost, 2024
$508K
1,559 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Elizabeth Roth was code 95012 (pulmonary), 41 times for 30 patients. In total Elizabeth Roth billed 828 services in 20 codes, and Medicare paid $25K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-03-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95012 Pulmonary | Office | 41 | 30 | $11.60 | $476 |
| 99214 Office E&M - Established | Office | 37 | 27 | $75.10 | $2,779 |
| 94375 Pulmonary Function Testing | Office | 30 | 24 | $22.57 | $677 |
| 99215 Office E&M - Established | Office | 24 | 21 | $108.77 | $2,610 |
| 99214 Office E&M - Established | Facility | 14 | 14 | $60.38 | $845 |
By year: 2022 $21K for 716 services; 2023 $30K for 1,151 services; 2024 $25K for 828 services.
Medicare prescription drug claims, 2024
In 2024, the drug Elizabeth Roth prescribed most often to Medicare patients was Montelukast Sodium, with 266 prescriptions and refills. In total Elizabeth Roth wrote 1,559 Medicare prescriptions that cost $508K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 266 | 540 | 71 | $3,143 |
| Fluticasone Propionate Generic | 210 | 369 | 71 | $3,556 |
| Dulera Mometasone/Formoterol | 193 | 218 | 45 | $78K |
| Levocetirizine Dihydrochloride Generic | 135 | 310 | 44 | $3,227 |
| Breo Ellipta Fluticasone/Vilanterol | 107 | 162 | 27 | $64K |
| Azelastine Hcl Generic | 105 | 145 | 32 | $2,636 |
| Ipratropium Bromide Generic | 86 | 108 | 26 | $3,478 |
| Spiriva Respimat Tiotropium Bromide | 55 | 75 | Under 11 | $39K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 44 | 52 | Under 11 | $33K |
| Incruse Ellipta Umeclidinium Bromide | 40 | 61 | Under 11 | $20K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 40 | 53 | 19 | $2,183 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 26 | 36 | Under 11 | $4,342 |
| Ventolin Hfa Albuterol Sulfate | 21 | 26 | 13 | $1,609 |
| Famotidine Generic | 20 | 41 | Under 11 | $78.29 |
| Tezspire Tezepelumab-Ekko | 18 | 18 | Under 11 | $74K |
Brand drugs: - claims; generic drugs: 932 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Elizabeth Roth were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.